Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome

Acta Obstet Gynecol Scand. 2007;86(9):1145-6. doi: 10.1080/00016340701343024.
No abstract available

MeSH terms

  • Antibodies, Antinuclear / blood
  • Antibodies, Antinuclear / immunology
  • Female
  • Glucocorticoids / therapeutic use*
  • Heart Block / congenital*
  • Heart Block / prevention & control*
  • Humans
  • Infant, Newborn
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / immunology
  • Plasmapheresis / methods*
  • Prednisolone / therapeutic use*
  • Pregnancy
  • Pregnancy Complications / blood*
  • Pregnancy Complications / immunology
  • Sjogren's Syndrome / blood
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / immunology
  • Treatment Outcome

Substances

  • Antibodies, Antinuclear
  • Glucocorticoids
  • SS-A antibodies
  • SS-B antibodies
  • Prednisolone